National Cancer Institute "Cancer Moonshot Biobank"
Recruiting
1,600 enrolled
PRO-ACTIVE
Recruiting
850 enrolled
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed
377 enrolled
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
BASECAMP-1
Recruiting
200 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Assessing the Time Demands of Cancer
Active not recruiting
78 enrolled 8 charts
TraveraRTGx
Recruiting
200 enrolled
COSMOS
Not yet recruiting
248 enrolled
OLAP
Completed
661 enrolled
Clinical Significance of Germline BRCA Mutations
Active not recruiting
13,320 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
PRIORITY
Completed
346 enrolled 9 charts
START
Terminated
10 enrolled
Assessment of Paclitaxel-Induced Neuropathy
Active not recruiting
43 enrolled
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Recruiting
3,300 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Completed
490 enrolled
LONGEVITI
Recruiting
75 enrolled
PREFER
Completed
1,429 enrolled
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Recruiting
6,000 enrolled
INSPIRE
Recruiting
5,350 enrolled
MOHCCN-O
Recruiting
500 enrolled
REFLECT
Recruiting
120 enrolled
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Recruiting
15,000 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
QUANTUM
Enrolling by invitation
3,000 enrolled
A-TRAIN
Unknown
506 enrolled
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Withdrawn
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
Completed
46 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Recruiting
2,700 enrolled
STILVARCA
Active not recruiting
275 enrolled
ASAP
Recruiting
25,000 enrolled
GYNECO-IMM&CO
Recruiting
160 enrolled
A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Completed
120 enrolled
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
CUSIOS
Completed
400 enrolled
POPCORN
Recruiting
782 enrolled
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Completed
16,506 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
Establishment of a Tumor Bank for Blood Samples
Recruiting
10,000 enrolled
Establishment of a Tumor Bank for Tissue Samples
Recruiting
10,000 enrolled
CADENCE
Unknown
15,000 enrolled